Abundant lipophilic DNA adducts in human tissues

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 422, Issue 2, 1998, Pages 285-295

  Yang, Ke ^a   Fang, Jia Long ^a,b   Hemminki, Kari ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Division of Biochemical Toxicology   (United States)

Author keywords

2,3 Epoxy 4 hydroxynonanal; Age; DNA adduct; Endogenous; Human; Lipophilic; Occupational; PAH; Smoking

Indexed keywords

CIGARETTE SMOKE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; AGING; ARTICLE; BREAST; COLON; CONTROLLED STUDY; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG; LUNG PARENCHYMA; LYMPHOCYTE; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SKIN; SMOKING;

ADULT; AGED; ALDEHYDES; BREAST; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; COLON; DEOXYGUANOSINE; DNA ADDUCTS; ENDOMETRIUM; EPOXY COMPOUNDS; FEMALE; HUMANS; LUNG; LYMPHOCYTES; MALE; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYCYCLIC HYDROCARBONS, AROMATIC; SKIN; SMOKING;

EID: 0032480945     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00210-3     Document Type: Article

References (35)

1. Phillips D.H., Hewer A., Martin C.N., Garner R.C., King M.M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 336:1988;790-792.
2. 32P -postlabelling assay J. Natl. Cancer Inst. 81:1989;341-347.
3. Perera F.P., Dickey C., Santella R., O'Neill J.P., Albertini R.J., Ottman R., Tsai W.Y., Mooney L.A., Savela K., Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis. 15:1994;2905-2910.
4. Chaudhary A.K., Nokubo M., Reddy G.R., Yeola S.N., Morrow J.D., Blair I.A., Marnett L.J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 265:1994;1580-1582.
5. 32P -postlabelling determination of DNA adducts of malonaldehyde in humans: total white blood cells and breast tissue Carcinogenesis. 16:1995;1847-1851.
6. 2-propanodeoxy-guanosine adducts as common DNA lesions in rodents and humans. Proc. Natl. Acad. Sci. USA. 91:1994;7491-7495.
7. 2-propanodeoxy-guanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res. 56:1996;452-456.
8. Hemminki K. DNA adducts, mutations and cancer. Carcinogenesis. 14:1993;2007-2012.
9. Denissenko M.F., Pao A., Tang M., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 274:1996;430-432.
10. MacLeod M.C., Powell K.L., Tran N. Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. Carcinogenesis. 16:1995;975-983.
11. Harris C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 51:1991;5023s-5044s. suppl.
12. Hemminki K., Yang K., Rajaniemi H., Tyndyk M., Likhachev A. Postlabelling-HPLC analysis of lipophilic DNA adducts from human lung. Biomarkers. 2:1997;341-347.
13. Sodum R.S., Chung F.-L. Structural characterization of adducts formed in the reaction of 2,3-epoxy-4-hydroxynonenal with deoxyguanosine. Chem. Res. Toxicol. 2:1989;23-28.
14. Yang K., Airoldi L., Pastorelli R., Restano J., Guanci M., Hemminki K. Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density areas. Chem. Biol. Interact. 101:1996;127-136.
15. Hemminki K., Rajaniemi H., Lindahl B., Moberger B. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res. 56:1997;4374-4377.
16. Bykov V.J., Hemminki K. UV-induced photoproducts in human skin explants analysed by TLC and HPLC-radioactivity detection. Carcinogenesis. 16:1995;3015-3019.
17. 32P -postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleotide 5′-monophosphates Carcinogenesis. 10:1989;1231-1239.
18. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, Vol. 32, Polynuclear Aromatic Compounds, Part 1. IARC, Lyon, 1983.
19. 32P -postlabeling assay Carcinogenesis. 13:1992;1053-1074.
20. Hou S.-M., Lambert B., Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis. 16:1995;1913-1917.
21. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, Vol. 38, Tobacco Smoking, IARC, Lyon, 1986.
22. 32P -postlabelling assay Carcinogenesis. 12:1991;503-508.
23. Tang D., Santella R.M., Blackwood A.M., Young T.L., Mayer J., Jaretzki A., Grantham S., Tsai W.Y., Perera F.P. A molecular epidemiological case-control study of lung cancer. Cancer Epidem. Biomarkers Prev. 4:1995;341-346.
24. 32P -postlabeling assay and possible significance for spontaneous tumor induction and aging Carcinogenesis. 7:1986;1615-1617.
25. Randerath K., van Golen K.L., Dragan Y.P., Pitot H.C. Effects of phenobarbital on I-compounds in liver DNA as a function of age in male rats fed two different diets. Carcinogenesis. 13:1992;125-130.
26. K. Randerath, D. Li, B. Moorthy, E. Randerath, I-compounds-endogenous DNA markers of nutritional status, ageing, tumour promotion and carcinogenesis, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Method for Detection of DNA Adducts, IARC Scientific Publication no. 124, IARC, Lyon, 1993, pp. 157-165.
27. De Flora S., Izzotti A., Randerath K., Randerath E., Bartsch H., Nair J., Balansky R., van Schooten F., Degan P., Fronza G., Walsh D., Lewtas J. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat. Res. 366:1996;197-238.
28. Randerath K., Putman K.L., Osterburg H.H., Johnson S.A., Morgan D.G., Finch C.E. Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutation Res. 295:1993;11-18.
29. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11:1991;81-128.
30. Wang M., Dhingra K., Hittelman W.N., Liehr J.G., de Andrade M., Li D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidem. Biomarkers Prev. 5:1996;705-710.
31. 32P -postlabeling assay Proc. Am. Assoc. Cancer Res. 36:1995;139.
32. Li D., Wang M., Liehr J.G., Randerath K. DNA adducts induced by lipids and lipid peroxidation products: possible relationships to I-compounds. Mutat. Res. 344:1995;117-126.
33. 2-(1,3-propano)-2′-deoxyguanosine 3′-phosphate adducts formed from 4-hydroxy-2-nonenal Chem. Res. Toxicol. 10:1997;1259-1265.
34. Sodum R.S., Chung F.-L. Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonenal. Cancer Res. 51:1991;137-143.
35. Chen H.-J.C., Chung F.-L. Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide. Chem. Res. Toxicol. 9:1996;306-312.